MUSCELLA, Antonella
 Distribuzione geografica
Continente #
EU - Europa 10.273
AS - Asia 7.459
NA - Nord America 7.042
SA - Sud America 1.280
AF - Africa 191
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 26.258
Nazione #
US - Stati Uniti d'America 6.804
SG - Singapore 3.408
IT - Italia 2.968
IE - Irlanda 2.532
RU - Federazione Russa 2.101
CN - Cina 1.291
HK - Hong Kong 1.096
BR - Brasile 1.056
VN - Vietnam 671
SE - Svezia 667
UA - Ucraina 528
DE - Germania 444
IN - India 339
FI - Finlandia 260
FR - Francia 259
GB - Regno Unito 177
KR - Corea 148
CA - Canada 128
AR - Argentina 92
MX - Messico 83
JP - Giappone 82
BD - Bangladesh 77
ZA - Sudafrica 70
PL - Polonia 63
IQ - Iraq 61
PK - Pakistan 50
ES - Italia 43
SN - Senegal 43
NL - Olanda 41
EC - Ecuador 40
TR - Turchia 39
BE - Belgio 38
ID - Indonesia 37
CZ - Repubblica Ceca 30
LT - Lituania 30
IR - Iran 29
AT - Austria 22
AE - Emirati Arabi Uniti 18
VE - Venezuela 18
CL - Cile 17
MA - Marocco 16
UZ - Uzbekistan 16
CO - Colombia 15
EG - Egitto 14
PY - Paraguay 14
TN - Tunisia 13
PE - Perù 12
SA - Arabia Saudita 12
NP - Nepal 11
BG - Bulgaria 10
IL - Israele 10
CH - Svizzera 9
MY - Malesia 9
DZ - Algeria 8
HU - Ungheria 8
KE - Kenya 8
BO - Bolivia 7
ET - Etiopia 7
JO - Giordania 7
RO - Romania 7
UY - Uruguay 7
AL - Albania 5
AZ - Azerbaigian 5
EU - Europa 5
JM - Giamaica 5
LB - Libano 5
PS - Palestinian Territory 5
RS - Serbia 5
SY - Repubblica araba siriana 5
AU - Australia 4
BA - Bosnia-Erzegovina 4
GT - Guatemala 4
PT - Portogallo 4
AM - Armenia 3
BH - Bahrain 3
GR - Grecia 3
KW - Kuwait 3
KZ - Kazakistan 3
PH - Filippine 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AO - Angola 2
BB - Barbados 2
BW - Botswana 2
BY - Bielorussia 2
BZ - Belize 2
CG - Congo 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
LV - Lettonia 2
MD - Moldavia 2
MU - Mauritius 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
Totale 26.239
Città #
Dublin 2.527
Lecce 2.464
Singapore 1.226
Hong Kong 1.021
San Jose 901
Moscow 652
Ashburn 651
Chandler 511
Dallas 466
Beijing 324
Jacksonville 286
New York 275
Ho Chi Minh City 240
Los Angeles 190
Wayanad 189
Lauterbourg 168
Hanoi 164
Princeton 161
Munich 157
Seoul 142
Santa Clara 139
São Paulo 126
Council Bluffs 108
Frankfurt am Main 99
Des Moines 98
Orem 82
Helsinki 79
Tokyo 78
Brooklyn 66
Bari 62
Chennai 57
Wilmington 57
Montreal 55
West Jordan 55
Ogden 54
Ann Arbor 50
Central District 50
Warsaw 50
Atlanta 48
Denver 48
London 47
Chicago 46
Lequile 44
Dakar 43
Johannesburg 42
Stockholm 42
Phoenix 41
Poplar 41
Rio de Janeiro 39
Mexico City 37
Brussels 35
Da Nang 35
Seelze 34
Rome 33
Boston 31
Houston 31
Toronto 31
Haiphong 30
Copertino 27
Kent 27
Manchester 26
San Pietro Vernotico 26
Baghdad 25
Falkenstein 25
Turku 25
Jinan 23
Seattle 23
The Dalles 23
Columbus 22
Lappeenranta 22
Ankara 21
Brno 21
Falls Church 21
Nuremberg 21
San Francisco 21
Guangzhou 20
Amsterdam 19
Milan 19
Boardman 18
Augusta 17
Bremen 17
Mumbai 17
San Mateo 17
Tianjin 17
Lahore 16
Querétaro 16
Belo Horizonte 15
Curitiba 15
Shanghai 15
Zhengzhou 15
Aradeo 14
Biên Hòa 14
Guayaquil 14
Porto Alegre 14
St Louis 14
Tashkent 14
Brasília 13
Goiânia 13
Guarulhos 13
Vienna 13
Totale 15.646
Nome #
A monoclonal antibody to mammalian Angiotensin II AT1 receptor recognises one of the Angiotensin II receptor isoforms expressed by the eels. 247
INJURY PREVENTION IN YOUNG SOCCER PLAYERS: RESULTS OF A PILOT STUDY 247
Exchequer motor game enhances geometric thinking and mood in first grade children 244
[Pt(O,O'-acac)(gamma-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway 238
ADP sensitizes ZL55 cells to the activity of cisplatin 236
A new platinum(II) complex with high cytotoxicity in human endometrial cancer HeLa cells. 234
[Pt(O,O'-acac)(γ-acac)(DMS)] induces autophagy and apoptosis in Skov-3 ovarian carcinoma cells 233
Inhibition of ZL55 cell proliferation by ADP via PKC-dependent signalling pathway 233
[Pt(O,O′-acac)(γ-acac)(DMS)] inhibits malignant pleural mesothelioma cells in vitro and in vivo 232
[Pt(O,O'-acac)(γ-acac)(DMS)] Induces Autophagy in Caki-1 Renal Cancer Cells 225
[Pt(O,O’-acac)(γ-acac)(DMS)] affects the intracellular Ca2+ homeostasis in MCF-7 breast cancer cells 221
A new platinum(II) complex with high cytotoxicity in human breast cancer MCF-7 cells. 219
[Pt(O,O’-acac)(γ-acac)(DMS)] exerts high and fast cytotoxicity in breast cancer cells in primary culture 217
Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma 217
A new platinum(II) complex with high cytotoxicity in normal and tumoural thyroid cell lines 216
A new platinum(II) complex with high cytotoxicity in human breast cancer MCF-7 cells 215
A new platinum (II) complex exerts higher cytotoxicity in tumoral than in normal human breast cells in primary culture. 215
[Pt(O,O'-acac)(gamma-acac)(DMS)] alters the expression of genes for cell cycle regulation and invasive function 212
Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells 210
ADP sensitizes ZL55 cells to the activity of anticancer cisplatin 209
[Pt(O,O’-acac)(γ-acac)(DMS)]: in vivo Studies of a Promising Anticancer Drug in Cancer Therapy 207
Antitumor and Antiangiogenic Activities of [Pt(O,O' acac)(γ-acac)(DMS)] in human renal cell carcinoma 204
[Pt(O,O’-acac)(γ-acac)(DMS)]: a comparative study with cisplatin in vivo. 201
Evaluation of the Antitumor Effects of Platinum-Based [Pt(η1-C2H4-OR)(DMSO)(phen)]+ (R = Me, Et) Cationic Organometallic Complexes on Chemoresistant Pancreatic Cancer Cell Lines 200
PKC-δ/PKC-α activity balance regulates the lethal effects of cisplatin 200
In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma 200
[Pt(O,O'-acac)(γ-acac)(DMS)] alters SH-SY5Y cell migration and invasion by the inhibition of Na+/H+ exchanger isoform 1 occurring through a PKC-ε/ERK/mTOR Pathway. 198
1H-NMR metabolomic study of SKOV-3 cells, response to the [Pt(O,O′-acac)(γ-acac)(DMS)] treatment 197
Antitumor and antimigration effects of a new Pt compound on neuroblastoma cells 193
Activation of P2Y2 purinoceptor inhibits the activity of the Na+/K+ATPase in HeLa cells 191
[Pt(O,O’-acac)(γ-acac)(DMS)] inhibits adhesion and migration of breast cancer cells 191
Cytotoxicity of new organometallic Pt(II)-complexes containing 1,10-phenantroline 191
Referees' physical performance over a soccer season 190
Antitumor activity of [Pt(O,O’-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer 190
Response of cisplatin resistant SkOV-3 cells to [PT(O,O'-Acac)(γ-Acac)(DMS)] Treatment revealed by a metabolomic 1H-NMR study 187
Cisplatin-analogous β-diketonate Pt(II) organometallic species: reactivity and cytotoxicity 183
Angiotensin II stimulates the Na+/H+ exchanger in human umbilical vein endothelial cells via AT1 receptor 183
Different apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary culture. 183
[Pt(O,O′-acac)(γ-acac)(DMS)] inhibits migration of tumor human breast cells in primary cultures 181
Antitumor and antimigration effects of Salvia clandestina L. extract on osteosarcoma cells 179
The effects of exercise training on lipid metabolism and coronary heart disease 178
Differential functions of PKC-delta and PKC-zeta in cisplatin response of normal and transformed thyroid cells. 177
Antitumor Effects Induced by the Promising Drug [Pt(O,O′-acac)(γ-acac)(DMS)] in Cisplatin Resistant Epithelial Ovarian Carcinoma Cell Line (SKOV-3): a 1H NMR Metabolomic Study 177
Activation of P2Y2 receptor induces C-Fos protein through a pathway Involving Mitogen-Activated Protein Kinase and phosphoinositide 3-kinases in HeLa cells. 176
A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells 175
Activation of angiotensin II type I receptor promotes protein kinase C translocation and cell proliferation in human cultured breast epithelial cells 173
[Pt(O,O’-acac)(γ-acac)(DMS)] induces apoptosis in human breast cancer cells in primary culture 173
Cisplatin activates the PKC/ERK1/2 intracellular transduction pathways in rat thyroid PC Cl3 cells 168
Cytotoxicity of [Pt(O,O’-acac)(γ-acac)(DMS)] in normal and cancerous human breast cells in primary culture 168
Transbulbar B-Mode Sonography in Multiple Sclerosis: Clinical and Biological Relevance 168
Is mitochondrial DNA profiling predictive for athletic performance? 168
An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects 167
Angiotensin II stimulation of the basolateral located Na/H antiporter in eel (Anguilla anguilla) enterocytes 166
The effects of training on hormonal concentrations in young soccer players 166
Differential response of normal, dedifferentiated and transformed thyroid cell lines to cisplatin treatment 165
Bradykinin stimulates prostaglandin E2 release in human skeletal muscular fibroblasts 164
The Angiosuppressive Effects of [Pt(O,O′-acac)(γ-acac)(DMS)] 161
Different regulation of matrix metalloproteinase-2 in cisplatin response of normal and transformed thyroid cells 160
NEW B-DIKETONATE PT(II) ORGANOMETALLIC SPECIES EXHIBITING HIGHER CYTOTOXIC ACTIVITY ON CANCER CELLS THAN CISPLATIN. 158
Multiple isoforms of the oestrogen receptor in endometrial cancer 157
Protein kinase C-delta mediates cisplatin-induced apoptosis of ZL55 mesothelioma cells 156
NMR-based metabolomic analyses of cisplatin resistant SKOV-3 cell line response to [Pt (O,O′-acac)(γ-acac)(DMS)], Ptac2S, treatment: comparison to cisplatin 156
Mitochondria-mediated apoptosis by a new Pt(II) compound, [Pt(O,O’-acac)(g-acac) (DMS)], in human breast cancer cells 155
Synthesis and characterization of new water-soluble organometallic complexes of the type [PtL(h1-C2H4OMe)(N^N)] (L = NH3, DMSO; N^N = dinitrogen ligand) with potential antitumor activity 155
Cytotoxic Activity of New β-Diketonate Platinum(II) Complexes on Cancer Cells 154
Adenosine diphosphate regulates MMP2 and MMP9 activity in malignant mesothelioma cells 154
Dopamine and antioxidant grape seed extract loaded chitosan nanoparticles: A preliminary in vitro characterization. 153
AT1 angiotensin II receptor subtype in the human larynx and squamous laryngeal carcinoma 153
A novel monoclonal antibody to a plasmamembrane-located breast cancer antigen Interferes with the proliferation rate of cancerous cells in vitro 153
CCL20 promotes migration and invasiveness of human cancerous breast epithelial cells in primary culture 153
Immunolocalization of the AT-1R Ang II Receptor in Human Kidney Cancer 151
Effect of tumour size on the association between pS2 and cathepsin D in primary breast cancer 150
Purinergic receptors in a pleural mesotelioma cell line. 150
Involvement of Protein Kinase Cdelta and -epsilon in cisplatin-induced apoptosis in thyroid cells. 149
Immunolocalisation of angiotensin II receptors in icefish (Chionodraco hamatus) tissues. 148
A new platinum(II) compound anticancer drug candidate with selective cytotoxicity for breast cancer cells 148
Synthesis, characterization and cytotoxic activity of novel Pt(II) complexes with acetylacetonate and amines 148
Angiotensin II AT1 Receptor Stimulates Na+/K+ATPase Activity Through a Pathway Involving PKC-z in Rat Thyroid Cells. 147
PKC-zeta is required for angiotensin II-induced activation of ERK and synthesis of C-FOS in MCF-7 cells 146
Monitoring Psychometric States of Recovery to Improve Performance in Soccer Players: A Brief Review 144
Synthesis and comparative evaluation of the cytotoxic activity of cationic organometallic complexes of the type [Pt(η1-CH2-CH2-OR)(DMSO)(phen)]+ (R = Me, Et, Pr, Bu) 144
EGFR MEDIATES THE CYTOTOXICITY OF CISPLATIN IN THE DIFFERENTIATED RAT THYROID PC CL3 CELL LINE THROUGH THE ACTIVATION OF MAPK/P38 143
PKC-epsilon-dependent cytosol-to-membrane translocation of pendrin in rat thyroid PC Cl3 cells. 142
ERK activation in cisplatin response in thyroid cell lines 141
Increase of [Ca2+]i via activation of ATP receptors in PC-Cl3 rat thyroid cell line 141
Angiotensin II modulates the activity of Na+/K+ATPase in cultured rat astrocytes via the AT1 receptor and protein kinase C-delta activation 139
Differential activation of ERK1/2 in human breast cancer MCF-7 cells treated with cisplatin or [Pt(O,O’-acac)(γ-acac)(DMS)] 139
Molecular Studies on Cisplatin Analogues 139
In vivo study on xenograft model: [Pt(O,O’-acac)(γ-acac)(DMS)] versus cisplatin 139
Angiotensin II stimulation of Na+/K+ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells. 138
A Practical Approach to Assessing Physical Freshness: Utility of a Simple Perceived Physical Freshness Status Scale 137
Effects of extracellular nucleotides in the thyroid: P2Y(2) receptor-mediated ERK1/2 activation and c-Fos induction in PC Cl3 cells 137
Cytotoxic activity in vitro of cisplatin and its analogous [Pt(acac)Cl(DMSO)]. 137
Involvement of Protein Kinase C-delta and -epsylon in cisplatin-induced apoptosis in thyroid cells 135
CCL20 induces migration and proliferation on breast epithelial cells 134
Transforming growth factor-β1 induces matrix metalloproteinase and cell migration in Schwann cells. 134
Efficacy of school-based intervention programs in reducing overweight: A randomized trial 131
Angiotensin II receptors in the gill of sea water- and freshwater-adapted eel 131
Different Cytotoxic Effects of Cisplatin on Pancreatic Ductal Adenocarcinoma Cell Lines 129
Cisplatin-related drugs for nongenomic targets: Forcing the reactivity with nucleobases 129
Totale 17.496
Categoria #
all - tutte 113.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.063


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021415 0 0 0 0 0 0 0 0 0 149 123 143
2021/2022802 14 4 54 78 109 12 22 49 21 64 118 257
2022/20234.325 192 334 173 132 156 268 29 189 2.681 14 98 59
2023/20241.581 132 91 107 92 133 158 22 58 221 307 173 87
2024/20255.122 98 29 109 80 342 558 180 249 1.679 538 477 783
2025/202611.064 1.086 1.413 1.024 1.550 1.243 570 1.365 534 1.615 664 0 0
Totale 26.621